SEC Filings

SEC Filing Details

Document Details

Form
Filing Date
Mar 16, 2021
Document Date
Mar 15, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Iovance Biotherapeutics, Inc.
Issuer
IOVANCE BIOTHERAPEUTICS, INC.
Filer
BILINSKY IGOR